Results 71 to 80 of about 2,602,946 (275)

El sulfuro de hidrógeno ejerce efectos anti-catabólicos en cartílago articular artrósico in vitro [PDF]

open access: yes, 2018
[Resumen] El sulfuro de hidrógeno (H2S), compuesto activo de las aguas mineromedicinales sulfuradas, ha demostrado ser un protector tisular en varias patologías.
Blanco García, Francisco J   +4 more
core  

Enfermedad del diafragma: reporte de un caso y revisión de la literatura

open access: yesRevista Colombiana de Gastroenterología
La obstrucción intestinal es una condición clínica que puede tener múltiples causas, entre ellas, y muy poco frecuente, el uso prolongado de antiinflamatorios no esteroideos (AINE).
Juan David Molina Marin   +1 more
doaj   +1 more source

Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 453-461, August 2025.
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos   +5 more
wiley   +1 more source

Avaliação ecotoxicológica de anti-inflamatórios e paracetamol em Chlorella vulgaris

open access: yesResearch, Society and Development
Atualmente, grande quantidade de substâncias são encontradas no ambiente aquático, sendo os fármacos, principalmente a classe dos anti-inflamatórios, encontrados neste meio.
Bárbara Letícia Ribeiro de Castro   +1 more
semanticscholar   +1 more source

Evaluación de la expresión de citoquinas en tejido asociado a mucosa de trucha arcoiris (Oncorhynchus mykiss) y de la dorada (Sparus aurata) [PDF]

open access: yes, 2017
Fish in aquaculture are permanently under the influence of various external stimuli, some of them can become stressors. Depending on their magnitude and duration, they may give rise to a physiological response with the aim of maintaining the body's ...
Soliva Dueso, Lluc
core  

Canakinumab: un anticuerpo monoclonal prometedor en el tratamiento de enfermedades cardiovasculares

open access: yesRevista Colombiana de Cardiología, 2013
El canakinumab es un anticuerpo monoclonal anti-IL-1β totalmente humano desarrollado por Novartis, cuyo mecanismo de acción se basa en la neutralización de la señalización IL-1β, lo cual conduce a la supresión de la inflamación en pacientes con ...
Fernando Manzur, MD., FACC   +1 more
doaj   +1 more source

A blinded randomised split‐body clinical trial evaluating the effect of fluorescent light energy on antimicrobial management of canine interdigital furunculosis

open access: yesVeterinary Dermatology, Volume 36, Issue 3, Page 291-301, June 2025.
Background – Canine interdigital furunculosis (CIF) is a complex, relapsing inflammatory condition, typically complicated by deep bacterial infections requiring prolonged systemic antibiotics. Hypothesis/Objectives – This split‐body study, where dogs acted as their own control, evaluated whether the adjunctive use of fluorescent light energy (FLE ...
A. Lange   +12 more
wiley   +1 more source

Expresión y rol del slpi (secretory leukocyte protease inhibitor) en la inmunidad innata del ojo asociado a procesos inflamatorios e infecciosos oculares. [PDF]

open access: yes, 2012
En la terapia antimicrobiana, se pretende comprender y desarrollar sinergia con los mecanismos de defensa innatos del huésped, en el área oftalmológica, los relacionados a procesos oculares infecciosos tanto específicos como no específicos. Conservando y
Berra, Alejandro   +5 more
core  

Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis

open access: yesVeterinary Dermatology, Volume 36, Issue 2, Page 165-176, April 2025.
Background – Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the control of cAD in a randomised, blinded trial.
Sophie Forster   +4 more
wiley   +1 more source

Treatment of moderate‐to‐severe canine atopic dermatitis with modified‐release mycophenolate (OKV‐1001): A pilot open‐label, single‐arm multicentric clinical trial

open access: yesVeterinary Dermatology, Volume 35, Issue 6, Page 652-661, December 2024.
Background – Mycophenolate is an immunomodulating agent successfully used for the treatment of moderate‐to‐severe atopic dermatitis (AD) in people. Mycophenolate is an effective steroid‐sparing treatment option for use in dogs with inflammatory skin diseases.
Michael Klotsman   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy